Dual antiplatelet therapy for secondary prevention of coronary artery disease

Dual antiplatelet therapy (DAPT) combining aspirin and a P2Y(12) receptor inhibitor has been consistently shown to reduce recurrent major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) for stable coronary art...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Heart
Autors principals: Degrauwe, Sophie, Pilgrim, Thomas, Aminian, Adel, Noble, Stephane, Meier, Pascal, Iglesias, Juan F
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2017
Matèries:
Interventional Cardiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652612/
https://ncbi.nlm.nih.gov/pubmed/29081979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2017-000651
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars